The impact of vagotonic, adrenergic, and random type of paroxysmal atrial fibrillation on left atrial ablation outcomes

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4015-4018

  Efremidis, Michael ^a   Letsas, Konstantinos P ^a   Lioni, Louiza ^a   Deftereos, Spyridon ^b   Giannopoulos, Georgios ^b   Kossyvakis, Charalampos ^b   Tsikrikas, Spyros ^a   Charalampous, Charalampos ^a   Kollias, George ^a   Xydonas, Sotirios ^a   Synetos, Andreas ^c   Sideris, Antonios ^a   Toutouzas, Konstantinos ^c   Stefanadis, Christodoulos ^c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adrenergic; Atrial fibrillation; Autonomic tone; Catheter ablation; Vagotonic

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; QUINIDINE; SOTALOL; ADRENERGIC RECEPTOR;

ABLATION THERAPY; ADRENERGIC ACTIVITY; ADULT; ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART CATHETER; HUMAN; HYPERTENSION; INCIDENCE; LEFT ATRIAL ABLATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT CODING; POPULATION RESEARCH; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; SYMPTOMATOLOGY; TREATMENT OUTCOME; VAGUS TONE; AGED; ATRIAL FIBRILLATION; CONTROLLED STUDY; HEART ATRIUM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURGERY; VAGUS NERVE;

ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGUS NERVE;

EID: 84886313567     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.075     Document Type: Article

References (29)

1. P. Coumel, P. Attuel, J. Lavalle, D. Flammang, J.F. Leclerq, and R. Slama The atrial arrhythmia syndrome of vagal origin Arch Mal Coeur Vaiss 71 1978 645 656
2. P. Coumel Neural aspects of paroxysmal atrial fibrillation R.H. Falk, P.J. Prodrid, Atrial fibrillation: mechanisms and management 1992 Raven Press New York NY 109 125
3. P. Coumel Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 15 Suppl. A 1994 9 16
4. P. Schauerte, B.J. Scherlag, and E. Patterson Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system J Cardiovasc Electrophysiol 12 2001 592 599
5. B.J. Scherlag, W. Yamanashi, U. Patel, R. Lazzara, and W.M. Jackman Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation J Am Coll Cardiol 45 2005 1878 1886
6. Y. Hou, B.J. Scherlag, and J. Lin Interactive atrial neural network: determining the connection between ganglionated plexi Heart Rhythm 4 2007 56 63
7. I. Ninomiya Direct evidence of nonuniform distribution of vagal effects on dog atria Circ Res 19 1966 576 583
8. R. Alessi, M. Nusynowitz, J.A. Abildskov, and G.K. Moe Nonuniform distribution of vagal effects on the atrial refractory period Am J Physiol 194 1958 406 410
9. D.P. Zipes, M.J. Mihalick, and G.T. Robbins Effects of selective vagal and stellate ganglion stimulation of atrial refractoriness Cardiovasc Res 8 1974 647 655
10. J.H. Burn, E.M. Vaughan Williams, and J.M. Walker Effects of acetylcholine in heart-lung preparation including the production of auricular fibrillation J Physiol 128 1955 277 293
11. E. Patterson, R. Lazzara, and B. Szabo Sodium-calcium exchange initiated by the Ca2 + transient: an arrhythmia trigger within pulmonary veins J Am Coll Cardiol 47 2006 1196 1206
12. E. Patterson, S. Po, B. Scherlag, and R. Lazzara Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation Heart Rhythm 2 2005 624 631
13. D.H. Pauza, V. Skripka, N. Pauziene, and R. Stropus Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart Anat Rec 259 2000 353 382
14. S.S. Po, B.J. Scherlag, and W.S. Yamanashi Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions Heart Rhythm 3 2006 201 208
15. E.M. Kanoupakis, E.G. Manios, H.E. Mavrakis, M.D. Kaleboubas, F.I. Parthenakis, and P.E. Vardas Relation of autonomic modulation to recurrence of atrial fibrillation following cardioversion Am J Cardiol 86 2000 954 958
16. H. Oral, A. Chugh, and C. Scharf Pulmonary vein isolation for vagotonic adrenergic and random episodes of paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 15 2004 402 405
17. R. Rosso, P.B. Sparks, and J.B. Morton Vagal paroxysmal atrial fibrillation: prevalence and ablation outcome in patients without structural heart disease J Cardiovasc Electrophysiol 21 2010 489 493
18. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
19. R.M. Lang, M. Bierig, and R.B. Devereux American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
20. K.P. Letsas, C.H. Siklódy, and P. Korantzopoulos The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation Int J Cardiol 164 2013 94 98
21. O.F. Sharifov, V.V. Fedorov, G.G. Beloshapko, A.V. Glukhov, A.V. Yushmanova, and L.V. Rosenshtraukh Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs J Am Coll Cardiol 43 2004 483 490
22. M. Bettoni, and M. Zimmermann Autonomic tone variations before the onset of paroxysmal atrial fibrillation Circulation 105 2002 2753 2759
23. A.G. Brooks, G. Rangnekar, and A.N. Ganesan Characteristics of ectopic triggers associated with paroxysmal and persistent atrial fibrillation: evidence for a changing role Heart Rhythm 9 2012 1367 1374
24. C.B. de Vos, R. Nieuwlaat, and H.J. Crijns Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey Eur Heart J 29 2008 632 639
25. J. Chen, S.L. Wasmund, and M.H. Hamdan Back to the future: the role of the autonomic nervous system in atrial fibrillation Pacing Clin Electrophysiol 29 2006 413 421
26. L. Mont, R. Elosua, and J. Brugada Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter Europace 11 2009 11 17
27. T. Liu, L. Li, P. Korantzopoulos, E. Liu, and G. Li Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Int J Cardiol 126 2008 160 170
28. F. Dentali, M. Gianni, and A. Squizzato Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis Thromb Haemost 106 2011 363 370
29. M. Annoura, M. Ogawa, K. Kumagai, B. Zhang, K. Saku, and K. Arakawa Cholesterol paradox in patients with paroxysmal atrial fibrillation Cardiology 921 1999 21 27